References
- Sussman LN, Miller EB. [New blood factor: Vel.] Rev Hematol 1952;7:368–71.
- Sussman LN. Current status of the Vel blood group system. Transfusion 1962;2:163–71.
- Levine P, Robinson EA, Herrington LB, Sussman LN. Second example of the antibody for the high-incidence blood factor Vel. Am J Clin Pathol 1955;25:751–4.
- Cedergren B, Giles CM, Ikin EW. The Vel blood group in northern Sweden. Vox Sang 1976;31:344–55.
- Peyrard T, Pham B, Arnaud L, et al. The Vel– rare blood phenotype in France: a 15-year experience. Transfusion 2010;50(Suppl):28A.
- Issitt P, Combs M, Carawan H, et al. Phenotypic association between Ge and Vel. Transfusion 1994;34:60S.
- Haer-Wigman L, Stegmann TC, Solati S, et al. Impact of genetic variation in the SMIM1 gene on Vel expression levels. Transfusion 2015;55:1457–66.
- Schechter Y, Chezar J, Levene C, et al. ABTI (901015), a new red cell antigen of high frequency. Transfusion 1996;36:25S.
- Banks J, Poole J, Das Gupta C, Lonicer C, Salama A. Two new cases of anti-ABTI showing an association between ABTI and Vel. Vox Sang 2004;87:38.
- Storry JR. Five new blood group systems—what next? ISBT Sci Ser 2014;9:136–40.
- Toivanen P, Hirvonen T. Fetal development of red cell antigens K, k, Lua, Lub, Fya, Fyb, Vel and Xga. Scand J Haematol 1969;6:49–55.
- Race RR, Sanger R. Blood groups in man. Oxford, UK: Blackwell Scientific Publications, 1975.
- Dunstan RA. Status of major red cell blood group antigens on neutrophils, lymphocytes and monocytes. Br J Haematol 1986;62:301–9.
- Storry JR, Joud M, Christophersen MK, et al. Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype. Nat Genet 2013;45:537–41.
- Wieckhusen C, Rink G, Scharberg EA, et al. Molecular screening for Vel– blood donors in southwestern Germany. Transfus Med Hemother 2015;42:356–60.
- Cvejic A, Haer-Wigman L, Stephens JC, et al. SMIM1 underlies the Vel blood group and influences red blood cell traits. Nat Genet 2013;45:542–5.
- Ballif BA, Helias V, Peyrard T, et al. Disruption of SMIM1 causes the Vel– blood type. EMBO Mol Med 2013;5:751–61.
- Rink G, Scharberg EA, Bugert P. PCR with sequence-specific primers for typing of diallelic blood groups. Methods Mol Biol 2015;1310:71–81.
- van der Harst P, Zhang W, Mateo Leach I, et al. Seventy-five genetic loci influencing the human red blood cell. Nature 2012;492:369–75.
- Christophersen MK, Jöud M, Thuresson B, et al. Genetic variants regulate expression of SMIM1 and the Vel blood group antigen. Vox Sang 2014;107:16.
- Ulirsch JC, Nandakumar SK, Wang L, et al. Systematic functional dissection of common genetic variation affecting red blood cell traits. Cell 2016;165:1530–45.
- Christophersen MK, Joud M, Ajore R, et al. SMIM1 variants rs1175550 and rs143702418 independently modulate Vel blood group antigen expression. Sci Rep 2017;7:40451.
- Arnaud L, Kelley LP, Helias V, Cartron JP, Ballif BA. SMIM1 is a type II transmembrane phosphoprotein and displays the Vel blood group antigen at its carboxyl-terminus. FEBS Lett 2015;589:3624–30.
- Solyakov L, Halbert J, Alam MM, et al. Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum. Nat Commun 2011;2:565.
- Issitt PD, Anstee DJ. Applied blood group serology. Miami, FL: Montgomery Scientific Publications, 1998.
- Mechanic SA, Maurer JL, Igoe MJ, Kavitsky DM, Nance ST. Anti-Vel reactivity diminished by adsorption with rabbit RBC stroma. Transfusion 2002;42:1180–3.
- Storry JR, Olsson ML, Moulds JJ. Rabbit red blood cell stroma bind immunoglobulin M antibodies regardless of blood group specificity. Transfusion 2006;46:1260–1.
- Reid ME, Lomas-Francis C, Olsson ML. The blood group antigen factsbook. London: Academic Press, 2012.
- Rainer T, Israel B, Caglioti S, Figueroa D. The effects of dithiothreitol-treated red blood cells with anti-Vel. Transfusion 2004;44:122A.
- Duran-Suarez JR. A human anti-Vel enhanced by sodium hypochlorite. Transfusion 2005;26:304–5.
- Danger Y, Danard S, Gringoire V, et al. Characterization of a new human monoclonal antibody directed against the Vel antigen. Vox Sang 2016;110:172–8.
- Storry JR, Mallory DM. Misidentification of anti-Vel due to inappropriate use of techniques. Immunohematology 1994;10:83–6.
- Le Masne A, Vachee A, Horbey C, et al. [Severe form of neonatal hemolytic disease by anti-Vel allo-immunization.] Arch Fr Pediatr 1992;49:899–901.
- Williams CK, Williams B, Pearson J, Steane SM, Steane EA. An example of anti-Vel causing mild hemolytic disease of the newborn. Transfusion 2005;25:462.
- Szaloky A, van der Hart M. An auto-antibody anti-Vel. Vox Sang 1971;20:376–7.
- Becton DL, Kinney TR. An infant girl with severe autoimmune hemolytic anemia: apparent anti-Vel specificity. Vox Sang 1986;51:108–11.